FDA orders starker warnings on opioid painkillers

The Food and Drug Administration is requiring stronger warning labels on prescription painkillers like OxyContin, in the government's latest attempt to reduce overdose deaths caused by the long-acting medications.

The changes announced Tuesday are designed to remind doctors and patients about the fatal risks of misusing and abusing opioid pain relievers, which include extended-release forms of oxycodone, hydrocodone and morphine.

The new label emphasizes that long-acting opioids are only for patients with "around-the-clock" pain that cannot be treated with over-the-counter medications or immediate-release opioids.

The FDA has issued a number of warnings about the dangers of in recent years but with little effect. Inappropriate use of opioids caused more than 16,650 in 2010, up more than 12 percent from 2008.

Related Stories

US panel opposes pure hydrocodone painkiller

date Dec 09, 2012

(AP)—U.S. government health experts overwhelmingly voted against a stronger version of hydrocodone on Friday, questioning the need for a new form of one of most widely abused prescription painkillers.

Opioid prescription is on the increase

date Feb 12, 2013

More and more opioids are being prescribed for pain relief in Germany. This is the conclusion arrived at by Ingrid Schubert, Peter Ihle, and Rainer Sabatowski, whose study of a sample of inhabitants of the state of Hesse ...

Recommended for you

US appeals court upholds delay in Alzheimer's drug swap

date May 22, 2015

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.